Sanome is a health technology company dedicated to enhancing patient care through AI-driven data insights. Their flagship product, MEMORI, is an AI-powered Clinical Decision Support (CDS) tool designed to assist clinical teams in identifying emerging risks in patients with acute neurological injuries and conditions. By integrating seamlessly into existing Electronic Patient Record (EPR) systems, MEMORI provides real-time, actionable insights, enabling earlier detection and intervention.
Key Features and Functionality:
- AI-Powered Risk Prediction: MEMORI utilizes advanced algorithms to analyze patient data, predicting potential deteriorations up to 72 hours earlier than traditional methods.
- Seamless EPR Integration: The tool embeds directly within existing EPR workflows, eliminating the need for additional logins or parallel systems.
- Explainable AI: MEMORI offers transparent insights into patient conditions, clarifying why deterioration may be occurring and suggesting appropriate next steps.
- Regulatory Compliance: MEMORI is a Class IIb CE-certified (EU MDR) and MHRA-registered Software as a Medical Device, ensuring adherence to stringent healthcare standards.
Primary Value and User Benefits:
Sanome's MEMORI addresses the critical challenge of hospital-acquired infections (HAIs), which affect approximately 300,000 patients annually in England, leading to significant morbidity, mortality, and financial costs. By enabling earlier detection of infection risks, MEMORI supports timely interventions, reducing the need for broad-spectrum antibiotics, lowering the risk of critical care admissions, and shortening hospital stays. For healthcare professionals, MEMORI streamlines data analysis, saving time and enhancing decision-making capabilities. For healthcare institutions, the tool contributes to improved patient outcomes, increased operational efficiency, and substantial cost savings.
